Canopy Growth Corp last reported quarterly results on Aug 7, 2026, for Q4 FY2026 (the quarter ended Jun 30, 2026). It usually reports 37–39 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 6, 2026.
Results for Q1 FY2027, the quarter ending around Sep 30, 2026. Expected on a Friday. Based on last year's release for the same quarter on Nov 7, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 37–39 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 7, 2026
38 days after quarter end
|
Q4 FY2026
ended Jun 30, 2026
|
—
|
—
|
—
|
|
Feb 6, 2026
37 days after quarter end
|
Q3 FY2026
ended Dec 31, 2025
|
—
|
—
|
—
|
|
Nov 7, 2025
38 days after quarter end
|
Q2 FY2026
ended Sep 30, 2025
|
—
|
—
|
—
|
|
Aug 8, 2025
39 days after quarter end
|
Q1 FY2026
ended Jun 30, 2025
|
—
|
—
|
—
|
|
May 30, 2025
60 days after quarter end
|
Q4 FY2025
ended Mar 31, 2025
|
—
|
—
|
—
|
|
Feb 7, 2025
38 days after quarter end
|
Q3 FY2025
ended Dec 31, 2024
|
—
|
—
|
—
|
|
Nov 8, 2024
39 days after quarter end
|
Q2 FY2025
ended Sep 30, 2024
|
—
|
—
|
—
|
|
Aug 9, 2024
40 days after quarter end
|
Q1 FY2024
ended Jun 30, 2024
|
—
|
—
|
—
|
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CGC (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Smith Falls, Ontario, Canada
- SEC filer status
- Accelerated filer
- SEC CIK
- 1737927
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.